Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
December 16, 2020 14:52 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, December 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of...
Bavarian Nordic sikrer anden del af koppevaccineordre fra den amerikanske regering
December 16, 2020 14:52 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 16. december 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Biomedical Advanced Research and Development Authority (BARDA), en del af Office of the Assistant Secretary...
Bavarian Nordic Introduces New Employee Incentive Program
December 08, 2020 14:05 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, December 8, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the board, in line with previous years, has decided to introduce a three-year incentive program...
Bavarian Nordic iværksætter nyt incitamentsprogram for medarbejdere
December 08, 2020 14:05 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. december 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen, i lighed med tidligere år, har besluttet at iværksætte et treårigt incitamentsprogram i januar...
Bavarian Nordic offentliggør storaktionærmeddelelse fra Invesco Ltd.
November 16, 2020 03:39 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 16.november 2020 – Bavarian Nordic A/S (OMX: BAVA) meddeler, at selskabet, i henhold til §38 i Lov om kapitalmarkeder samt §55 og §56 i Selskabsloven, har modtaget meddelelse fra...
Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.
November 16, 2020 03:39 ET
|
Bavarian Nordic A/S
Copenhagen, Denmark, November 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the Company, as set out in Section 38 in the Danish Capital Markets Act and section 55, cf. 56 of...
Correction: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
November 13, 2020 06:21 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 13, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) publishes corrected information about the following transactions of the company’s shares/related securities by...
Correction: Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
November 13, 2020 06:21 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. november 2020 – Bavarian Nordic A/S (OMX: BAVA) offentliggør korrigerede oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af...
Health Canada Extends Approval of IMVAMUNE to Immunization against Monkeypox and Orthopox Viruses
November 12, 2020 02:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine,...
Health Canada udvider godkendelsen af IMVAMUNE til beskyttelse mod abekopper og orthopoxvira
November 12, 2020 02:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 12. november 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Health Canada har udvidet godkendelsen af selskabets ikke-replikerende koppevaccine, IMVAMUNE®, til at...